0001123292-17-001368.txt : 20170821 0001123292-17-001368.hdr.sgml : 20170821 20170821175644 ACCESSION NUMBER: 0001123292-17-001368 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170821 FILED AS OF DATE: 20170821 DATE AS OF CHANGE: 20170821 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mattila Jyrki CENTRAL INDEX KEY: 0001297318 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36329 FILM NUMBER: 171043830 MAIL ADDRESS: STREET 1: AUXILIUM PHARMACEUTICALS, INC. STREET 2: 40 VALLEY STREAM PARKWAY CITY: MALVERN STATE: PA ZIP: 19355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Recro Pharma, Inc. CENTRAL INDEX KEY: 0001588972 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261523233 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (484) 395-2400 MAIL ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2017-08-21 0001588972 Recro Pharma, Inc. REPH 0001297318 Mattila Jyrki C/O RECRO PHARMA, INC. 490 LAPP ROAD MALVERN PA 19355 0 1 0 0 Executive VP, Business Dev. Employee Stock Option (right to buy) 6.98 2017-08-21 4 A 0 75000 0 A 2027-08-21 Common Stock 75000 75000 D Restricted Stock Units 2017-08-21 4 A 0 12000 0 A Common Stock 12000 12000 D The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company. The stock option is an inducement grant under NASDAQ listing rule 5635(c)(4). Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. The restricted stock units vest in four equal annual installments beginning August 21, 2018. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date. The restricted stock unit award is an inducement grant under NASDAQ listing rule 5635(c)(4). /s/ Ryan D. Lake, attorney-in-fact 2017-08-21